Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

Thailand

Thai FDA registration and public funding are separate decisions. NLEM selection uses clinical review and, where needed, economic assessment and price negotiation; the relevant scheme, patient conditions, procurement and supply determine implementation.

Thai FDA
Thai NLEM clinical expert groups
Thai NLEM economic assessment groups
Thai NLEM negotiation groups / public funds
Thai public schemes / providers
5 decision nodes11 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it